2024 JP Morgan Healthcare Conference
BRUKER'S TRANSFORMATION INTO A FAST GROWTH COMPANY
Unique capabilities: MALDI Biotyper® with Novel Applications
Installed Base Grows Steadily, >50% Recurring Revenues
▪ Leader in microbial ID by proteomic fingerprinting in clinical and applied markets
▪ Faster and more cost-effective ID of bacteria and fungi
Near-universal microbial species coverage from cultures
■
MALDI Biotyper" sirius
Technology Leadership
▪ MALDI-TOF technology leadership
▪ MALDI Biotyper® sirius enables
novel lipidomics assays - Ruo
Sepsityper accelerates US growth
▪ MBT Compass: 600 samples/hr
2023 Bruker
■
MALDI Biotyper sirius
CARE
02
MBT Sepsityper IVD Kit
BRUKER
Market Expansion & Installed Base Growth
>6,000 MALDI Biotyper® customer systems
▪ >100 million IDs per year
▪ >50% of revenues recurring, >10% CAGR of
assay, consumables and service aftermarket
I
Innovation with Integrity | January 8, 2024
I
7View entire presentation